Walk into any pharmacy in winter and you will find shelves stacked with zinc lozenges and selenium capsules, both marketed under the broad banner of “immune support.” The claims range from reasonable to wild, and most shoppers have no idea which side of that line they are standing on. The science is more interesting and more specific than the marketing suggests – two minerals, two very different mechanisms, and a body of randomised trial data that rewards anyone willing to read past the label.
Both zinc and selenium are essential trace minerals the body cannot synthesise and must obtain from food or supplementation. Their functions touch everything from immune cell replication to thyroid hormone conversion and DNA repair. Understanding what the evidence actually says – and where it stops saying anything reliable – is the difference between a useful supplement strategy and an expensive habit with no payoff.
What Zinc Actually Does in the Immune System
Zinc is one of the most studied micronutrients in immunology, and for good reason. It functions as a structural component or catalytic cofactor in over 300 enzymes, many of them directly involved in immune cell proliferation and signalling. Without adequate zinc, T-lymphocyte development stalls, natural killer cell activity falls, and the inflammatory signalling cascade becomes dysregulated in ways that impair both the initial response to pathogens and the resolution of inflammation afterward.
The Recommended Dietary Allowance set by the NIH Office of Dietary Supplements is 8 mg/day for adult women and 11 mg/day for adult men. Pregnant and breastfeeding women need more – 11 to 13 mg depending on life stage. The tolerable upper intake level for adults sits at 40 mg/day; beyond that, chronic high-dose supplementation begins to interfere with copper absorption, which creates its own set of deficiency problems. These numbers matter because the supplement aisles frequently sell products containing 50 mg or even higher per tablet, which is above the safety threshold for daily use.
Food sources put these figures in perspective. An 85g serving of oysters provides around 74 mg of zinc. More practical daily contributors are beef (7 mg per 85g), crab (6.5 mg), pumpkin seeds (2.2 mg per 28g), and fortified breakfast cereals (up to 3.8 mg per serving). A varied diet including red meat or shellfish a few times a week will typically meet the RDA without supplementation.
The Cold Duration Evidence: What Hemila and Chalker Found
The most practically useful finding in zinc supplementation research concerns the common cold. Finnish researcher Harri Hemila has published multiple analyses on zinc lozenge trials, and the consistency of the signal across studies is notable. A 2017 meta-analysis published in JRSM Open (Hemila) pooling data from seven randomised controlled trials found that the mean duration of the common cold was 33% shorter in the zinc groups compared to placebo – a result with a 95% confidence interval of 21% to 45%, which is statistically robust.
The catch is formulation. Zinc acetate lozenges perform better than zinc gluconate in most analyses, and dose matters. Studies using at least 75 mg of elemental zinc per day as lozenges – not tablets swallowed whole – show the strongest effects. When zinc is chelated with citric acid or sorbitol, ionic zinc gets bound up and the effect disappears. The mechanism involves ionic zinc blocking the rhinovirus receptor ICAM-1 in the nasal passages – which is why the slowly dissolving lozenge format is biologically meaningful, not just a delivery preference. Treatment must begin within the first 24 hours of symptom onset; starting later reduces or eliminates the benefit.
It is worth being precise about what this data does not show. Zinc lozenges have not been demonstrated to prevent colds, and the trials are specifically for duration of an already-active infection. The 33% figure also applies to total duration, not severity of individual symptoms, although Hemila’s 2015 analysis in BMC Family Practice did show that nasal discharge was shortened by 34%, cough by 46%, and muscle ache by 54% in zinc acetate lozenge trials. These are genuinely useful numbers for someone deciding whether to keep a pack in the medicine cabinet, provided the product contains the right formulation and dose.
Selenium: A Narrower Window, a Different Set of Risks
Selenium’s immune role operates through a different mechanism. The mineral is incorporated into a class of proteins called selenoproteins, of which there are 25 identified in humans. Several of these – including glutathione peroxidases and thioredoxin reductases – are antioxidant enzymes that protect immune cells from oxidative damage. Selenium also appears to support T-cell activation and the activity of natural killer cells. When selenium status is low, viral mutations may actually be accelerated because the host’s antioxidant defences are weaker, allowing greater viral replication and genetic drift – a finding documented in studies of Coxsackievirus and influenza conducted at Chapel Hill.
The NIH ODS sets the RDA for selenium at 55 micrograms per day for adults – a modest amount readily achieved through diet. Brazil nuts are the most concentrated source: a single nut can contain 68 to 91 mcg depending on soil content. More practical daily contributors include tuna (92 mcg per 85g), halibut (47 mcg), sardines (45 mcg), and beef (28 mcg per 85g). Wheat and rice also contribute selenium in amounts that vary with the mineral content of the soil in which they were grown.
The NPC Trial and What It Actually Proved
The Nutritional Prevention of Cancer (NPC) trial, conducted by Larry Clark and colleagues in the 1990s, is frequently cited in selenium supplement marketing. The trial enrolled 1,312 participants with a history of skin cancer and randomised them to 200 mcg/day of selenium as selenised yeast or placebo. The primary endpoint – nonmelanoma skin cancer recurrence – showed no significant benefit. However, secondary analyses showed intriguing reductions in total cancer incidence and in prostate, colorectal, and lung cancer specifically in participants who entered the trial with lower baseline selenium status. Lung cancer incidence had a hazard ratio of 0.56, meaning roughly a 44% reduction in that subgroup.
Those secondary findings generated enormous interest but were not confirmed in larger prospective trials – most significantly the SELECT trial (Selenium and Vitamin E Cancer Prevention Trial), which enrolled over 35,000 men and found no reduction in prostate cancer risk from 200 mcg/day selenium supplementation. The current consensus is that the NPC secondary findings do not justify high-dose selenium supplementation to prevent cancer, and the SELECT trial’s non-significant trend toward harm in some subgroups adds additional caution.
Upper Limits and Why They Exist
Selenium toxicity is a genuine clinical concern in a way that many other trace minerals are not. The European Food Safety Authority (EFSA) set the tolerable upper intake level for adults at 300 mcg/day in its 2000 assessment, a figure it subsequently revised downward to 255 mcg/day in its 2023 reassessment based on updated toxicological data. In the United States, the Institute of Medicine (now the National Academy of Medicine) sets the UL at 400 mcg/day. The gap between the RDA of 55 mcg and the UL of 255 to 400 mcg may look large, but high-dose supplements of 200 mcg taken alongside a selenium-rich diet can bring someone uncomfortably close to the safety boundary.
Selenosis – selenium toxicity – presents with a distinctive cluster of symptoms: a garlic odour on the breath caused by the exhalation of dimethyl selenide, brittle nails, hair loss, gastrointestinal disturbance, and in severe cases neurological symptoms including fatigue and irritability. Chronic exposures above the UL have been associated with these effects in populations living in selenium-rich geological areas in China. The takeaway is not that selenium is dangerous at normal dietary intakes, but that supplementation doses should be selected with awareness of what the diet already provides, and that the 200 mcg/day dose used in NPC – while inside the US UL – should not be treated as a casual daily addition without a clinical rationale.
Food First vs. Supplement Strategy
The clearest takeaway from the trial data is that both minerals deliver their benefits most reliably when the starting point is a documented deficiency or inadequate dietary intake. For zinc, populations at genuine risk include older adults, vegetarians and vegans (plant-based zinc has lower bioavailability due to phytate binding), and people with inflammatory bowel disease. For selenium, geographic variation matters – populations in parts of Europe, New Zealand, and inland China have historically lower soil selenium and therefore lower dietary intakes. For everyone else eating a varied diet, the exception that holds up best in the randomised evidence is zinc acetate lozenges for an active cold started within the first 24 hours – a very specific application the data genuinely supports. Beyond that, knowing which foods are richest in each mineral and eating them with reasonable frequency is more useful than a supplement that may overshoot the safe range without measurable return.
This article is for general informational purposes only and does not constitute medical advice. Consult a qualified healthcare professional before starting any supplementation regimen.